A Phase I Study of Telomerase-specific Replication Competent Oncolytic Adenovirus (Telomelysin) for Various Solid Tumors
Open Access
- 28 February 2010
- journal article
- Published by Elsevier BV in Molecular Therapy
- Vol. 18 (2), 429-434
- https://doi.org/10.1038/mt.2009.262
Abstract
No abstract availableThis publication has 52 references indexed in Scilit:
- Diagnostic and therapeutic application of telomerase-specific oncolytic adenoviral agentsFrontiers in Bioscience-Landmark, 2008
- Survivin-Driven and Fiber-Modified Oncolytic Adenovirus Exhibits Potent Antitumor Activity in Established Intracranial GliomaHuman Gene Therapy, 2007
- Antitumor Activity of an Oncolytic Adenovirus-Delivered Oncogene Small Interfering RNACancer Research, 2006
- Oncolytic viral therapy for human cancer: Challenges revisitedDrug Development Research, 2005
- Ad-mTERT-Δ19, a Conditional Replication-Competent Adenovirus Driven by the Human Telomerase Promoter, Selectively Replicates in and Elicits Cytopathic Effect in a Cancer Cell-Specific MannerHuman Gene Therapy, 2003
- Transcriptional targeting of conditionally replicating adenovirus to dividing endothelial cellsGene Therapy, 2002
- Identification of Distinct Roles for a Dileucine and a Tyrosine Internalization Motif in the Interleukin (IL)-13 Binding Component IL-13 Receptor α2 ChainOnline Journal of Public Health Informatics, 2001
- Tumor-specific gene transfer via an adenoviral vector targeted to the pan-carcinoma antigen EpCAMGene Therapy, 1999
- Characterization of Factors Involved in Modulating Persistence of Transgene Expression from Recombinant Adenovirus in the Mouse LungHuman Gene Therapy, 1997
- Adenovirus proteins that subvert host defensesTrends in Microbiology, 1994